2 for 1: Targeting tumor-associated macrophages and cancer cells with a novel MERTK-targeting antibody-drug conjugate (ADC)

被引：0
|
作者：
Takeda, Shugaku
Lo, PuiChi
Schefer, Daniel
Siddiqui, Maryam
Tyagi, Anudishi
Battula, Venkata Lokesh
Maiti, Abhishek
Tavazoie, Sohail
Tavazoie, Masoud
Darst, David Martin
Kurth, Isabel
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-B122
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B122
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Development of novel MUC1-C targeting antibody-drug conjugate for pancreatic cancer treatment
    Ahmad, Rehan
    Panchamoorthy, Govind
    Raina, Deepak
    Lawney, Brian
    Kharbanda, Surender
    Jasuja, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer
    Junttila, Melissa R.
    Mao, Weiguang
    Wang, Xi
    Wang, Bu-Er
    Thinh Pham
    Flygare, John
    Yu, Shang-Fan
    Yee, Sharon
    Goldenberg, David
    Fields, Carter
    Eastham-Anderson, Jeffrey
    Singh, Mallika
    Vij, Rajesh
    Hongo, Jo-Anne
    Firestein, Ron
    Schutten, Melissa
    Flagella, Kelly
    Polakis, Paul
    Polson, Andrew G.
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (314)
  • [23] Preclinical development of a novel antibody-drug conjugate targeting "cold" tumors
    Kaplan, Angelo
    Attanasio, Nickolas
    Do, To Uyen T.
    Swaminathan, Sudha
    Bisht, Arnima
    Lou, San Lin
    Allen, Jason
    Boyd, Robert
    Ackroyd, James E.
    Feldman, Gleb
    Rohlff, Christian
    Dusek, Rachel L.
    CANCER RESEARCH, 2018, 78 (13)
  • [24] A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies
    Kim, S. Y.
    Theunissen, J-W
    Balibalos, J.
    Liao-Chan, S.
    Babcock, M. C.
    Wong, T.
    Cairns, B.
    Gonzalez, D.
    van der Horst, E. H.
    Perez, M.
    Levashova, Z.
    Chinn, L.
    D'Alessio, J. A.
    Flory, M.
    Bermudez, A.
    Jackson, D. Y.
    Ha, E.
    Monteon, J.
    Bruhns, M. F.
    Chen, G.
    Migone, T-S
    BLOOD CANCER JOURNAL, 2015, 5 : e316 - e316
  • [25] Targeting tumor-associated macrophages to combat pancreatic cancer
    Cui, Ran
    Yue, Wen
    Lattime, Edmund C.
    Stein, Mark N.
    Xu, Qing
    Tan, Xiang-Lin
    ONCOTARGET, 2016, 7 (31) : 50735 - 50754
  • [26] Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer
    Li, Mei-Ye
    Ye, Wei
    Luo, Ke-Wang
    PHARMACEUTICS, 2024, 16 (07)
  • [27] Antibody-drug conjugate targeting tissue factor for pancreatic cancer treatment
    Tsumura, Ryo
    Anzai, Takahiro
    Manabe, Shino
    Takashima, Hiroki
    Koga, Yoshikatsu
    Yasunaga, Masahiro
    Matsumura, Yasuhiro
    CANCER SCIENCE, 2021, 112 : 725 - 725
  • [28] A Traceless Vascular-Targeting Antibody-Drug Conjugate for Cancer Therapy
    Bernardes, Goncalo J. L.
    Casi, Giulio
    Truessel, Sabrina
    Hartmann, Isabelle
    Schwager, Kathrin
    Scheuermann, Joerg
    Neri, Dario
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (04) : 941 - 944
  • [29] A novel pegylated biparatopic antibody-drug conjugate (pb-adc) targeting cancers with low HER2+ expression
    Liu, Shumin
    Yin, Shuqiang
    Lyu, Weidong
    Lei, Yang
    Zhuo, Qiudong
    Wu, Zibin
    Tan, Shuangyu
    Zheng, Liling
    Wen, Yu
    Wu, David
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Spatially targeting of tumor-associated macrophages and cancer cells for suppression of spontaneously metastatic tumor
    Zhou, Minglu
    Xie, Dandan
    Zhou, Zhou
    Li, Lian
    Huang, Yuan
    NANO RESEARCH, 2022, 15 (04) : 3446 - 3457
12345